These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26047847)

  • 21. Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester human placenta and embryonic tissues.
    Chong WS; Kwan PC; Chan LY; Chiu PY; Cheung TK; Lau TK
    Hum Reprod; 2005 Dec; 20(12):3532-8. PubMed ID: 16123094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria represent another locale for the divalent metal transporter 1 (DMT1).
    Wolff NA; Garrick LM; Zhao L; Garrick MD; Thévenod F
    Channels (Austin); 2014; 8(5):458-66. PubMed ID: 25483589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1).
    Cadieux JA; Zhang Z; Mattice M; Brownlie-Cutts A; Fu J; Ratkay LG; Kwan R; Thompson J; Sanghara J; Zhong J; Goldberg YP
    Bioorg Med Chem Lett; 2012 Jan; 22(1):90-5. PubMed ID: 22154351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC11 family of H+-coupled metal-ion transporters NRAMP1 and DMT1.
    Mackenzie B; Hediger MA
    Pflugers Arch; 2004 Feb; 447(5):571-9. PubMed ID: 14530973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic basis of the inhibition of SLC11/NRAMP-mediated metal ion transport by bis-isothiourea substituted compounds.
    Manatschal C; Pujol-Giménez J; Poirier M; Reymond JL; Hediger MA; Dutzler R
    Elife; 2019 Dec; 8():. PubMed ID: 31804182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.
    Minor EA; Kupec JT; Nickerson AJ; Narayanan K; Rajendran VM
    Am J Physiol Cell Physiol; 2020 Feb; 318(2):C263-C271. PubMed ID: 31721611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the uptake of iron from Fe(II) ascorbate and Fe(III) citrate by IEC-6 cells and the involvement of ferroportin/IREG-1/MTP-1/SLC40A1.
    Thomas C; Oates PS
    Pflugers Arch; 2004 Jul; 448(4):431-7. PubMed ID: 15114483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DMT1: which metals does it transport?
    Garrick MD; Singleton ST; Vargas F; Kuo HC; Zhao L; Knöpfel M; Davidson T; Costa M; Paradkar P; Roth JA; Garrick LM
    Biol Res; 2006; 39(1):79-85. PubMed ID: 16629167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights into the Physiology of Iron Transport: An Interdisciplinary Approach.
    Zaugg J; Pujol Giménez J; Cabra RS; Hofstetter W; Hediger MA; Albrecht C
    Chimia (Aarau); 2022 Dec; 76(12):996-1004. PubMed ID: 38069794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium.
    Ma Y; Specian RD; Yeh KY; Yeh M; Rodriguez-Paris J; Glass J
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G965-74. PubMed ID: 12223357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells.
    I Bannon D; Portnoy ME; Olivi L; Lees PS; Culotta VC; Bressler JP
    Biochem Biophys Res Commun; 2002 Jul; 295(4):978-84. PubMed ID: 12127992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DMT1 and iron transport.
    Yanatori I; Kishi F
    Free Radic Biol Med; 2019 Mar; 133():55-63. PubMed ID: 30055235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1.
    Illing AC; Shawki A; Cunningham CL; Mackenzie B
    J Biol Chem; 2012 Aug; 287(36):30485-96. PubMed ID: 22736759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron.
    Lane DJ; Robinson SR; Czerwinska H; Bishop GM; Lawen A
    Biochem J; 2010 Nov; 432(1):123-32. PubMed ID: 20819077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing Iron Overload: A Gut Check.
    Garrick MD
    J Pharmacol Exp Ther; 2023 Jul; 386(1):1-3. PubMed ID: 37321645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of iron status on DMT1 expression in duodenal enterocytes from beta2-microglobulin knockout mice.
    Moos T; Trinder D; Morgan EH
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G687-94. PubMed ID: 12181184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation.
    Cutts A; Chowdhury S; Ratkay LG; Eyers M; Young C; Namdari R; Cadieux JA; Chahal N; Grimwood M; Zhang Z; Lin S; Tietjen I; Xie Z; Robinette L; Sojo L; Waldbrook M; Hayden M; Mansour T; Pimstone S; Goldberg YP; Webb M; Cohen CJ
    J Pharmacol Exp Ther; 2023 Jul; 386(1):4-14. PubMed ID: 36958846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian iron transporters: families SLC11 and SLC40.
    Montalbetti N; Simonin A; Kovacs G; Hediger MA
    Mol Aspects Med; 2013; 34(2-3):270-87. PubMed ID: 23506870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Cases of Hypochromic Microcytic Anemia Due to Mutations in the
    Romero-Cortadellas L; Hernández G; Ferrer-Cortès X; Zalba-Jadraque L; Fuster JL; Bermúdez-Cortés M; Galera-Miñarro AM; Pérez-Montero S; Tornador C; Sánchez M
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake.
    Wetli HA; Buckett PD; Wessling-Resnick M
    Chem Biol; 2006 Sep; 13(9):965-72. PubMed ID: 16984886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.